To identify the SLCs that may function in cancer prognosis, we conducted survival analysis for all SLCs and identified SLCs that relate to patient survival (survival-related SLC genes, denoted as SRSGs, p < 0.05, |hazard ratio-1.0| > 0.1) in all cancer types. This evidence concerns the gene CCL21 and cancer.